BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2003
View Archived Issues
Nycomed obtains marketing license for Almogran in Nordic region
Read More
FluINsure delivers strong immunogenicity data in phase II trials
Read More
Amylin submits NDA amendment for Symlin
Read More
Data reported for pramipexole in Parkinson's disease and restless legs syndrome
Read More
Novel series of acylides with potent in vivo activity against Gram-positive pathogens
Read More
Effective stimulation of erythropoiesis reported for CERA in preclinical and clinical studies
Read More
LY-307161 SR confirmed to be an effective glucose-lowering drug in type 2 diabetes
Read More
Improved glycemic control with inhaled insulin compared to rosiglitazone in type 2 diabetics
Read More
Ruboxistaurin in diabetic neuropathy and retinopathy
Read More
Two studies confirm the potential benefits of NN-414 in type 2 diabetes
Read More
NN-2211 improves glycemia and sensitivity to glucose in patients with type 2 diabetes
Read More
Genentech and Biogen collaborate on BR3 protein therapeutic
Read More
Arixtra approved for extended use
Read More
Hollis-Eden and CFFT study HE-2000 in cystic fibrosis
Read More
Gaboxadol enters phase III testing for primary insomnia
Read More
MCH1 antagonist reduces body weight gain by decreasing food intake
Read More
Potential of EB-1089 in the treatment of B-CLL
Read More
Roche claims two novel series of A2A receptor ligands
Read More
Ezetimibe approved in Canada
Read More
New BCAT inhibitors and their use claimed by the former Warner-Lambert
Read More
Novel antiobesity MCH antagonists in early development at Schering-Plough
Read More
Nippon Chemiphar patent covers new xanthine oxidase inhibitors for use in gout and hyperuricemia
Read More
Dual adenosine A1/A2A antagonists in Fujisawa development pipeline
Read More
Pfizer researchers describe new neuronal nAChR ligands for nicotine addiction
Read More
New antiplatelet agent of fungal origin identified by Aventis
Read More
Shiseido synthesizes new MMP inhibitors
Read More
